Dannhardt; Gerd

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dannhardt; Gerd.The latest application filed is for "3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment".

Company Profile

1.17.13

Dannhardt; Gerd - Mainz DE
Dannhardt; Gerd - Eschborn DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment Grant 11,045,449 - Mohler , et al. June 29, 2	2021-06-29
3-(5-Fluoroindolyl)-4-arylmaleimide Compounds and their Use in Tumor Treatment App 20200253930 - Kind Code	2020-08-13
3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma Grant 9,364,459 - Dannhardt , et al. June 14, 2	2016-06-14
3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment Grant 9,012,659 - Dannhardt , et al. April 21, 2	2015-04-21
Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment Grant 8,957,103 - Dannhardt , et al. February 17, 2	2015-02-17
Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management Grant 8,841,319 - Dannhardt , et al. September 23, 2	2014-09-23
Conjugated 3-(indolyl)- And 3-(azaindolyl)-4-arylmaleimide Compounds And Their Use In Tumor Treatment App 20130345281 - Dannhardt; Gerd ; et al.	2013-12-26
3-(indolyl)- Or 3-(azaindolyl)- 4-arylmaleimide Compounds And Their Use In Tumor Treatment App 20130131060 - Dannhardt; Gerd ; et al.	2013-05-23
3-(indolyl)- Or 3-(azaindolyl)- 4-arylmaleimide Derivatives For Use In The Treatment Of Colon And Gastric Adenocarzinoma App 20130029986 - Dannhardt; Gerd ; et al.	2013-01-31
3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors Grant 8,008,320 - Dannhardt , et al. August 30, 2	2011-08-30
Use Of 3-(indolyl)- Or 3-(azaindolyl)-4-arylmaleimide Derivatives In Leukenia Management App 20110028415 - Dannhardt; Gerd ; et al.	2011-02-03
3-(indolyl)-4-arylmaleimide Derivatives And Their Use As Angiogenesis Inhibitors App 20090306124 - Dannhardt; Gerd ; et al.	2009-12-10
Non-glycosidic and non-peptidic inhibitors of selectin, and the use thereof Grant 7,485,742 - Dannhardt , et al. February 3, 2	2009-02-03
Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof App 20070276036 - Dannhardt; Gerd ; et al.	2007-11-29
2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors App 20070185169 - Dannhardt; Gerd ; et al.	2007-08-09
2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors Grant 7,223,781 - Dannhardt , et al. May 29, 2	2007-05-29
Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylac- etic acid Grant 7,078,535 - Dannhardt , et al. July 18, 2	2006-07-18
Topical use of bis-arylimidazo[1,2-a]thiolane derivatives App 20050276764 - Kolbe, Ludger ; et al.	2005-12-15
2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors App 20040116695 - Dannhardt, Gerd ; et al.	2004-06-17
[A]-anellated pyrrole derivatives and their use in pharmacology Grant 5,958,943 - Laufer , et al. September 28, 1	1999-09-28
[a]-Annelated pyrrole derivatives and pharmaceutical use thereof Grant 5,942,535 - Laufer , et al. August 24, 1	1999-08-24
[A]-annellated pyrrole derivatives and their use in pharmacology Grant 5,939,415 - Laufer , et al. August 17, 1	1999-08-17
Substituted pyrrole compounds and use thereof in pharmaceutical compositions Grant 5,260,451 - Dannhardt , et al. November 9, 1	1993-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.